VKTXViking TherapeuticsHealth Care
$32.74EarningsJul 29, 2026
1D1W1M3M1Y
Market cap$3.8BCompany infoRevenue$0.0052-wk range$23 – $42IndustryBiotechnologyWebsitevikingtherapeutics.comRelated
Market Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
+56.3% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E
P / S
P / FCF
EV / EBITDA
P / E (fwd)
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin
Operating margin
Net margin
ROE-67.5%15
-68%
-14%
ROIC-79.0%12
-79%
-10%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009895
0.0
0.0
Net debt / EBITDA
Current ratio5.729491
Interest coverage-15687.4×01
Per shareTTM, with year-over-year change
Revenue / share$0.00
EPS (diluted)$-4.14▼ −260%
FCF / share$-2.94▼ −154%
Est. EPS growth (fwd)